000			01995 a2200505 4500
005			20250517160946.0
264		0	_c20190904
008			201909s 0 0 eng d
022			_a1610-0387
024	7		_a10.1111/ddg.13272 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchmidgen, Maria Isabel
245	0	0	_aPembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma. _h[electronic resource]
260			_bJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG _cJul 2017
300			_a742-745 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Comparative Study; Letter; Randomized Controlled Trial
650	0	4	_aAntibodies, Monoclonal, Humanized _xadverse effects
650	0	4	_aComplement C3 _xmetabolism
650	0	4	_aDapsone _xtherapeutic use
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Hypersensitivity _xdrug therapy
650	0	4	_aFluorescent Antibody Technique, Direct
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLichen Planus _xchemically induced
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aMouth Mucosa _xdrug effects
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplasm Staging
650	0	4	_aPemphigoid, Bullous _xchemically induced
650	0	4	_aSkin _xdrug effects
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aStomatitis _xchemically induced
700	1		_aButsch, Florian
700	1		_aSchadmand-Fischer, Simin
700	1		_aSteinbrink, Kerstin
700	1		_aGrabbe, Stephan
700	1		_aWeidenthaler-Barth, Beate
700	1		_aLoquai, Carmen
773	0		_tJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG _gvol. 15 _gno. 7 _gp. 742-745
856	4	0	_uhttps://doi.org/10.1111/ddg.13272 _zAvailable from publisher's website
999			_c27285067 _d27285067